238 related articles for article (PubMed ID: 11387062)
21. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
22. Systematic determination of the packaging limit of lentiviral vectors.
Kumar M; Keller B; Makalou N; Sutton RE
Hum Gene Ther; 2001 Oct; 12(15):1893-905. PubMed ID: 11589831
[TBL] [Abstract][Full Text] [Related]
23. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
24. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory DS; Neugeboren BA; Mulligan RC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Kuate S; Wagner R; Uberla K
J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977
[TBL] [Abstract][Full Text] [Related]
26. Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses.
Sastry L; Xu Y; Johnson T; Desai K; Rissing D; Marsh J; Cornetta K
Mol Ther; 2003 Nov; 8(5):830-9. PubMed ID: 14599817
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
28. A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.
Kubo S; Mitani K
J Virol; 2003 Mar; 77(5):2964-71. PubMed ID: 12584321
[TBL] [Abstract][Full Text] [Related]
29. A synthetic Rev-independent bovine immunodeficiency virus-based packaging construct.
Molina RP; Ye HQ; Brady J; Zhang J; Zimmerman H; Kaleko M; Luo T
Hum Gene Ther; 2004 Sep; 15(9):865-77. PubMed ID: 15353041
[TBL] [Abstract][Full Text] [Related]
30. Development of multigene and regulated lentivirus vectors.
Reiser J; Lai Z; Zhang XY; Brady RO
J Virol; 2000 Nov; 74(22):10589-99. PubMed ID: 11044103
[TBL] [Abstract][Full Text] [Related]
31. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.
Xu K; Ma H; McCown TJ; Verma IM; Kafri T
Mol Ther; 2001 Jan; 3(1):97-104. PubMed ID: 11162316
[TBL] [Abstract][Full Text] [Related]
32. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral vectors for gene therapy of HIV-1 infection.
Mautino MR
Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
[TBL] [Abstract][Full Text] [Related]
34. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
35. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
Srinivasakumar N; Chazal N; Helga-Maria C; Prasad S; Hammarskjöld ML; Rekosh D
J Virol; 1997 Aug; 71(8):5841-8. PubMed ID: 9223473
[TBL] [Abstract][Full Text] [Related]
36. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors.
Cockrell AS; Ma H; Fu K; McCown TJ; Kafri T
Mol Ther; 2006 Aug; 14(2):276-84. PubMed ID: 16516556
[TBL] [Abstract][Full Text] [Related]
37. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.
Srinivasakumar N; Schuening FG
J Virol; 1999 Nov; 73(11):9589-98. PubMed ID: 10516068
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.
D'Costa J; Brown HM; Kundra P; Davis-Warren A; Arya SK
J Gen Virol; 2001 Feb; 82(Pt 2):425-434. PubMed ID: 11161282
[TBL] [Abstract][Full Text] [Related]
39. Construction of stable packaging cell lines for clinical lentiviral vector production.
Sanber KS; Knight SB; Stephen SL; Bailey R; Escors D; Minshull J; Santilli G; Thrasher AJ; Collins MK; Takeuchi Y
Sci Rep; 2015 Mar; 5():9021. PubMed ID: 25762005
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
